0
Marcaine™ (Bupivacaine) + Epinephrine 0.25% | 50mL Injectable MDV
PFZ-00409175250
Pfizer
-
RX License on File Required to Order
Detail
Anesthetics
Marcaine™ with Epinephrine (PFZ-00409175250) is a local anesthetic solution formulated for use in various medical and dental procedures where regional anesthesia is required. Containing 0.25% bupivacaine, a long-acting anesthetic, and epinephrine, a vasoconstrictor, this injectable solution provides effective and prolonged pain relief. The 50 mL multiple-dose vial ensures ample supply for multiple applications, making it suitable for both small and large procedures.
Features and Benefits:
- 0.25% Bupivacaine: Marcaine™ contains 0.25% bupivacaine, a potent local anesthetic known for its long duration of action. Bupivacaine provides effective pain control by blocking nerve signals in the targeted area, making it ideal for procedures requiring extended anesthesia.
- Epinephrine Addition: The inclusion of epinephrine (1:200,000) in the formulation acts as a vasoconstrictor. This helps to reduce blood flow to the area of injection, thereby prolonging the duration of anesthesia and reducing bleeding during procedures. Epinephrine also enhances the effectiveness of the anesthetic by slowing its absorption into the bloodstream.
- Multiple-Dose Vial: The 50 mL multiple-dose vial is designed for ease of use in clinical settings, allowing for multiple injections from a single container. This reduces the need for frequent vial changes and minimizes waste, contributing to cost-effective and efficient patient care.
- Extended Pain Relief: Due to its long-acting properties, Marcaine™ with Epinephrine provides extended pain relief, making it suitable for procedures that require prolonged anesthesia, such as surgeries and dental work.
- Safe and Effective: Marcaine™ is formulated to ensure a high level of safety and efficacy. It is manufactured under strict quality control standards to provide consistent performance and reliability.
